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ations may safeguard the kidney against irreversible functionalAcute cholestatic liver disease protects against glycerol-induced
and structural injury in the hepatorenal syndrome.acute renal failure in the rat.
Background. It is widely held that liver disease predisposes
toward acute tubular necrosis. The present study examines the
effect of acute cholestatic liver disease on the susceptibility to The view is entrenched in clinical practice and teachingglycerol-induced acute tubular necrosis in the rat.
that liver disease predisposes to the occurrence of acuteMethods. Acute cholestatic liver disease was induced by liga-
tubular necrosis [1–4]. Acute tubular necrosis occurs intion of the common bile duct, while the intramuscular injection
of hypertonic glycerol was used to induce acute tubular necrosis. settings in which the kidney is exposed to ischemic or
Renal injury was assessed by plasma creatinine concentration nephrotoxic insults, and such insults are considered more
and renal histology. An in vitro model of heme protein-induced likely to instigate acute tubular necrosis when liver func-
renal injury (hemoglobin in conjunction with glutathione deple-
tion is concomitantly and significantly impaired by he-tion) was employed to assess the cytoprotective effects of bili-
patocellular or cholestatic lesions [1–4]. Patients withrubin.
Results. Ligation of the common bile duct markedly reduced significant liver disease are thus regarded as having an
acute renal injury that occurs in the glycerol model (7.5 mL/kg increased risk for acute tubular necrosis when they ex-
body weight), as evidenced by a lower plasma creatinine con- perience systemic hypotension, as may occur in the peri-
centration and less severe renal histologic injury. At a higher operative period, when they are exposed to potentiallydose of glycerol (10 mL/kg body weight), ligation of the com-
nephrotoxic agents or endogenous toxicants such as hememon bile duct again reduced renal injury and cumulative mor-
proteins, or when systemic sepsis supervenes during thetality that occurs five days after the induction of this model of
acute renal failure. These protective effects of ligation of the clinical course of these patients [1–4]. These clinical ob-
common bile duct could not be ascribed to less severe muscle servations are supported by findings derived from disease
injury or red cell damage. Ligation of the common bile duct models wherein obstructive jaundice in the rat sensitizes
induced heme oxygenase-1 in the kidney and markedly so in
the kidney to injury induced by ischemic insults [5, 6],the liver. Inhibition of heme oxygenase significantly attenuated,
gentamicin [7], and endotoxin [8].but did not prevent, the protective effects conferred by ligation
The present study examines the effect of acute chole-of the common bile duct. Bilirubin, in low micromolar concen-
trations, was cytoprotective against heme protein-induced cell static liver disease in the rat on the susceptibility to
injury in vitro. glycerol-induced acute tubular necrosis. This study con-
Conclusions. Ligation of the common bile duct confers resis- tinues a line of investigation that seeks to determine thetance to glycerol-induced acute tubular necrosis in the rat, ac-
nature of responses instigated in the kidney sequentiallytions that arise, in part, from the induction of heme oxygenase-1
exposed to similar or dissimilar insults [9–12]. Such re-in the kidney and liver. Bilirubin, in micromolar concentrations,
protects against heme protein-induced renal injury. Our studies sponses are germane to the overarching issue of the deter-
uncover a novel form of acquired resistance to renal injury, minants of susceptibility to renal injury in general and
occurring, unexpectedly, in the setting of acute cholestatic liver to the phenomenon of acquired resistance of the kidney
disease. We speculate that such potentially cytoprotective alter-
to injury, in particular, wherein the kidney, subjected to
a given insult, acquires resistance to the same or different
insult [13–18]. As utilized in prior studies [9–12], theKey words: bile duct ligation, hepatorenal syndrome, bilirubin, renal
injury, cytoprotection, heme protein-induced nephrotoxicity. present study employs the glycerol model of acute tubu-
lar necrosis in the rat since this insult not only offers aReceived for publication February 6, 2001
long-established and widely utilized model of nephro-and in revised form April 6, 2001
Accepted for publication April 13, 2001 toxic acute tubular necrosis [19], but it also represents
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responses recruited in the injured kidney [9, 18, 20]. For divided [2, 5–8]. Sham-operated rats underwent laparot-
omy and mobilization of the gut without manipulationexample, in this model, there is a marked and rapid
induction of heme oxygenase-1 in the kidney, and such or ligation of the bile duct. The abdomen was closed
with 4-0 catgut in two layers. Both groups of rats hadinduction of heme oxygenase-1 confers a cytoprotective
response: Inhibiting heme oxygenase in this model wors- free access to tap water and standard rat chow prior to
and after surgery.ens renal injury, while the prior induction of heme oxy-
genase in the kidney protects against glycerol-induced,
Glycerol-induced acute renal failureheme protein-mediated, renal injury [9, 20].
The end products of heme oxygenase activity include Six days after ligation of the common bile duct or sham
operation, the glycerol model was induced by the intra-the bile pigments, biliverdin and bilirubin. Heme oxy-
genase is the rate-limiting enzyme in the degradation of muscular injection of 50% glycerol solution in rats anes-
thetized with ether and deprived of water over the pre-heme, converting heme to biliverdin in the course of
which iron is released and carbon monoxide evolves; ceding 16 hours [9–12]. In separate protocols, doses of
hypertonic glycerol of 7.5 and 10 mL/kg body weightbiliverdin is subsequently converted to bilirubin via the
enzyme biliverdin reductase [21–23]. Bilirubin is thus were employed. Renal function was evaluated by the
concentration of plasma creatinine, the latter determinedone of the main products of heme oxygenase; the latter,
when induced in stressed tissues, may confer a cytopro- by the Jaffe´ method using a Beckman Creatinine Ana-
lyzer II (Beckman Instruments, Fullerton, CA, USA) ontective response. Moreover, there is an evolving body of
data demonstrating the antioxidant and cytoprotective tail vein blood samples drawn just prior to and 24 hours
after the administration of glycerol. This is a valideffects of bilirubin in certain conditions [24–27]. There
is thus a curious irony with regards to bilirubin and the method for the determination of plasma creatinine in
the setting of liver disease, and in particular, this methodsusceptibility to renal injury. On the one hand, bilirubin,
produced as a consequence of the induction of heme oxy- is not significantly influenced by high concentrations of
bilirubin, which may interfere with certain assays forgenase-1, may confer a cytoprotective response [21–27];
on the other hand, plasma bilirubin is markedly elevated plasma creatinine [28]. Moreover, protocols were under-
taken in our study that attest to the reliability and repro-in advanced liver disease, the latter condition widely
recognized as one that predisposes to renal injury and ducibility of this method for the measurement of plasma
creatinine in the presence of concentrations of bilirubinacute tubular necrosis [1–4]. These considerations raise
the issue of whether advanced liver disease poses, invari- that encompass those achieved following the ligation of
the common bile duct (vide infra).antly, an increased risk for acute renal disease and
whether circumstances exist such that hyperbilirubinemia, Renal histology was evaluated 48 hours after the ad-
ministration of glycerol (50%, 7.5 mL/kg body weight)or some other feature of hepatic insufficiency, may en-
able liver disease to serve as a protector against, rather to rats that six days previously were subjected to common
bile duct ligation or sham operation. The kidneys werethan a facilitator of, renal damage.
In the present study, acute cholestatic liver disease perfusion fixed in 10% formalin and subsequently pro-
cessed in the standard fashion for examination by lightand attendant hyperbilirubinemia were induced in the
rat by ligation of the common bile duct, and the effect of microscopy [11, 12].
The glycerol model (7.5 mL/kg body weight) was alsothis manipulation on the glycerol-induced, heme protein-
mediated model of acute tubular necrosis was examined. induced in additional cohorts of rats subjected to com-
mon bile duct ligation or sham operation to assess theIn the course of these studies, we analyzed the involve-
ment of heme oxygenase-1 in contributing to the modula- relative alterations in plasma concentrations of markers
of muscle and red cell injury and hepatic injury; in thesetory effect observed with prior ligation of the common
bile duct and the effect of bilirubin on cellular injury studies, plasma creatine phosphokinase (CK) activity,
hemoglobin, and lactate dehydrogenase (LDH) activityinduced in an in vitro model of heme protein-induced
nephrotoxicity. were measured six hours after the administration of hy-
pertonic glycerol. As previously described, plasma CK
activity was measured by a colorimetric method based on
METHODS
the production of phosphorus using a Sigma Diagnostics
Ligation of the common bile duct Creatine Phosphokinase kit (St. Louis, MO, USA) [11].
Plasma hemoglobin concentrations were determined byAll studies were performed on male Sprague-Dawley
rats weighing between 250 and 325 g. Ligation of the com- the method described by Winterbourn [11, 29], while
LDH activity was measured by determining the ratemon bile duct or sham operation was performed under
anesthesia with intraperitoneal methohexithal (50 mg/kg of formation of nicotinamide adenine dinucleotide
(NADH) [11].body weight). Following an upper midline abdominal
incision, the bile duct was isolated, triply ligated, and Additional protocols assessed the effect of ligation
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of the common bile duct when acute renal failure was to the determination of plasma levels of bilirubin in bile
duct-ligated and sham-operated rats seven days afterinduced by a higher dose of glycerol (10 mL/kg body
weight). Rats subjected to ligation of the common bile ligation of the bile duct.
duct or sham operation were subjected to intramuscular
Heme protein-induced cytotoxicity: Effect of bilirubininjection of glycerol (10 mL/kg body weight) adminis-
tered six days after ligation of the common bile duct The effect of bilirubin on toxicity to LLC-PK1 cells
induced by hemoglobin and 1-chloro-2,4-dinitrobenzeneor sham operation. Concentrations of plasma creatinine
were determined prior to and 24 hours after the injection (CDNB) in the absence and presence of varying concen-
trations of bilirubin was assessed by measurement ofof glycerol. Both groups were followed for five days,
after which rats were sacrificed. LDH release; this in vitro model of heme protein-medi-
ated nephrotoxicity and its assessment are described pre-To determine the involvement of heme oxygenase in
the reduction in renal injury induced by prior ligation of viously in detail [30]. LLC-PK1 cells (American Type Cul-
ture Collection, Rockville, MD, USA) were cultured inthe common bile duct, rats subjected to sham operation
or common bile duct ligation were treated with the inhib- Dulbecco’s modified Eagle’s medium (DMEM) with 10%
fetal bovine serum (FBS), seeded onto 24-well cultureitor of heme oxygenase, tin protoporphyrin (20 mol/kg
body weight, subcutaneously administered) [9, 10], or plates, and studied as confluent monolayers 24 hours later.
All washes and incubations were done in Hanks’ balancedvehicle, 15 and 3 hours before the administration of
hypertonic glycerol, 7.5 mL/kg body weight. Plasma cre- salt solution containing 5 mmol/L HEPES (HBSSH). Af-
ter washing the cell monolayers with HBSSH, the mono-atinine concentrations were determined after the admin-
istration of tin protoporphyrin and just prior to the ad- layers were incubated for one hour at 37C with 20 mol/L
of hemoglobin in HBSSH or HBSSH alone and in theministration of glycerol, and again at 24 hours after the
administration of glycerol. absence or presence of increasing concentrations of bili-
rubin; concentrations of bilirubin of 2.5, 5, and 10mol/L
Northern analysis in 50 mol/L human serum albumin were employed and
were prepared from an initial stock solution of bilirubin,RNA was extracted from the kidney and liver using
the Trizol method (GIBCO BRL, Gaithersburg, MD, 2.5 mmol/L in 0.05 N NaOH. Following this incubation,
the media were removed and replaced with HBSSH withUSA), as previously described [11, 12], and undertaken
seven days after ligation of the common bile duct or or without CDNB (25mol/L) and in the absence or pres-
ence of bilirubin of 2.5, 5, and 10 mol/L in 50 mol/Lsham operation. Twenty micrograms of total RNA from
each sample were separated on an agarose gel and trans- human serum albumin. The cells were then incubated
for an additional three hours at 37C after which LDHferred to a nylon membrane. Membranes were hybrid-
ized overnight with a 32P-labeled mouse heme oxygenase-1 release was determined, as previously described [30].
cDNA probe. Autoradiograms were standardized, as pre-
Statisticsviously described [11, 12], by factoring the optical density
of the message for heme oxygenase-1 with the optical Results are expressed as means SEM and are consid-
ered statistically significant for P 0.05. For comparisondensity of the 18S rRNA, the latter obtained on a nega-
tive of the ethidium bromide-stained nylon membrane. between unpaired groups, the Student t test or the Mann-
Whitney test was employed as appropriate. For compari-
Heme oxygenase activity/plasma concentration son involving multiple groups, analysis of variance and
of bilirubin the Student-Neumann-Keul tests were employed. Data
pertaining to survival following the administration ofHeme oxygenase activity was measured by determin-
ing the generation of bilirubin by microsomes prepared glycerol were evaluated using Fisher’s exact test.
from kidneys, as described previously [9], and under-
taken seven days after ligation of the common bile duct
RESULTS
or sham operation. Kidney microsomes were incubated
Studies employing the glycerol model at a dosewith rat liver cytosol (as a source of biliverdin reductase),
of 7.5 mL/kg body weighthemin (20mol/L), glucose-6-phosphate (2 mmol/L), glu-
cose-6-phosphate-dehydrogenase (0.2 U), and NADPH Initial cohorts of 7 and 13 rats were subjected to sham
operation or ligation of the common bile duct, respec-(0.8 mmol/L) for one hour at 37C in the dark. The
formed bilirubin was extracted with chloroform and tively. Intramuscular hypertonic glycerol was adminis-
tered six days after this procedure, and at this time point,OD 464 to 530 nm was measured (extinction coefficient,
40 mmol/L1 · cm1 for bilirubin), and enzyme activity was the body weights of rats subjected to ligation of the com-
mon bile duct were significantly reduced as comparedexpressed as pmol of bilirubin formed/60 min/mg pro-
tein. This spectrophotometric method for the measure- with their body weights prior to surgery (304  2 vs.
255  5 g, P  0.01); the body weights of the sham-ment of the concentration of bilirubin was also applied
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0.4 and 0.5 mg/dL just prior to the administration of
glycerol, and given the rapidity of their demise after glyc-
erol, it is likely that this represented death from nonrenal
causes. In subsequent protocols, common bile duct liga-
tion reduced acute mortality observed with more severe
forms of glycerol-induced acute renal failure (vide infra).
Striking attenuation in glycerol-induced renal histo-
logic injury accompanied this protection against renal
dysfunction conferred by prior ligation of the common
bile duct. Figure 2 demonstrates representative photomi-
crographs of the kidney in these two groups; as shown
in Figure 2A (low power) and 2B (high power), rats that
were subjected to sham operation demonstrated, as ex-
pected, prominent proximal tubular necrosis and intratu-
bular cast formation. The histologic integrity of the kid-
Fig. 1. Effect of ligation of the common bile duct or sham operation ney in rats subjected to common bile duct ligation prior
on renal function, as measured by the concentration of plasma creatinine to the administration of glycerol was remarkably pre-prior to and one day following the intramuscular administration of hyper-
served; in particular, proximal tubular epithelial cell ne-tonic glycerol (7.5 mL/kg body weight). Day 0 represents plasma creati-
nine concentrations just prior to the administration of glycerol (7.5 crosis and intratubular cast formation were both rarely
mL/kg body weight) to rats that, six days previously, were subjected to observed (Fig. 2C, low power, and Fig. 2D, high power).ligation of the common bile duct () or sham operation (). Day 1
To determine whether these protective effects wererefers to measurements of plasma creatinine concentration undertaken
one day after the injection of intramuscular glycerol (7.5 mL/kg body due to lessening of myolysis or hemolysis, we measured
weight) in these two groups. *P  0.05 vs. plasma creatinine concentra- in rats that underwent common bile duct ligation or shamtion in rats subjected to sham operation.
operation an index of muscle injury (CK), an index of red
blood cell injury (plasma hemoglobin concentration),
and an index of red cell, muscle, liver, and other cellular
injury (LDH) after the administration of glycerol. Asoperated rats, while significantly less as compared with
their body weights prior to sham surgery, were better demonstrated in Figure 3, CK was not significantly differ-
ent in these groups, while plasma hemoglobin and LDHmaintained (292  1 vs. 285  1 g, P  0.01); one rat
in the common bile duct-ligated group died before intra- were both significantly higher in rats that underwent
ligation of the common bile duct. Thus, the protectivemuscular glycerol was administered. The hematocrit, just
prior to the administration of glycerol (and after the us- effects of common bile duct ligation cannot be ascribed
to reduction in muscle injury, red blood cell, or otherual overnight dehydration prior to this procedure), was
higher in rats subjected to ligation of the common bile types of cellular damage.
In these studies, glycerol was dosed according to bodyduct as compared with rats subjected to sham operation
(56  1 vs. 61  1%, P  0.02). weight, as is the standard and accepted practice regarding
the use of this model [19]. As recognized in the literatureFigure 1 demonstrates the plasma creatinine concen-
trations in rats subjected to ligation of the common bile [2, 5–7] and as occurred in our studies described pre-
viously in this article (vide supra), rats subjected to liga-duct or sham operation just prior to the administration
of intramuscular glycerol (Fig. 1, day 0) and again the tion of the common bile duct as compared with rats
subjected to sham operation may exhibit greater loss ofday after the administration of glycerol (Fig. 1, day 1). The
plasma creatinine concentration, prior to the administra- body weight. For example, six days after ligation of the
common bile duct, the mean body weight in these ratstion of glycerol, was mildly but significantly elevated in
rats subjected to ligation of the common bile duct as com- is some 50 g lighter than the body weight prior to surgery.
In an attempt to minimize these sizable differences inpared with the rats subjected to sham operation. As ex-
pected, the administration of intramuscular glycerol led body weight prior to the administration of glycerol, an-
other protocol was employed in which ligation of theto a marked rise in plasma creatinine concentration one
day thereafter in the sham-operated animals, achieving common bile duct was performed in rats some 50 g
greater in weight than those subjected to sham operationan increment of 2.8 mg/dL above basal values. In marked
contrast, the rise in plasma creatinine concentration one (258  1 vs. 305  2 g, P  0.05); six days after ligation
of the common bile duct or sham surgery and just priorday after the administration of glycerol (0.3 mg/dL) was
considerably reduced in rats previously subjected to com- to the administration of glycerol, the body weight of the
common bile duct-ligated rats more closely approxi-mon bile duct ligation. Two rats in the common bile duct
ligation group died shortly after the administration of glyc- mated the body weight of the rats subjected to sham
operation, but was still significantly lower by 14 g (254erol; plasma creatinine concentrations in these rats were
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Fig. 2. Representative histologic sections of the kidney stained with hematoxylin and eosin in rats two days after the administration of glyc-
erol (7.5 mL/kg body weight) and that, six days previously, were subjected to either sham operation (A, low power, 100; B, high power, 400)
or ligation of the common bile duct (C, low power, 100; and D, high power, 400). The kidney in sham-operated rats subjected to glycerol-
induced acute renal failure demonstrates extensive necrosis of proximal tubules and intratubular cast formation; the distal tubules and glomeruli
are relatively well preserved (A and B). In contrast, the kidney in the common bile duct ligated rat subjected to glycerol-induced acute renal
failure demonstrates remarkable preservation of histologic integrity with a relative lack of proximal tubular epithelial cell necrosis and intratubular
cast formation (C and D).
4 vs. 240 1 g body weight, P 0.05). To obviate further administered a higher dose of glycerol as dosed per
body weight and when the differences in body weightany effect related to body weight, the dose of glycerol
administered to rats with common bile duct ligation were minimized, rats subjected to common bile duct
ligation were again resistant to glycerol-induced acute(7.5 mL/kg body weight) was based on the mean body
weight of the sham-operated rat, in essence, administer- renal failure.
To examine the mechanisms that may underlie such cy-ing a dose of glycerol comparable, in absolute amounts,
to that administered to the sham-operated group, but in toprotection, we considered the possibility that induction
of heme oxygenase-1 may be involved. This view wasfact greater, as factored for body weight, than the dose
administered to the sham-operated rats. Again, and de- predicated on previous studies from our laboratory dem-
onstrating the protective effect of heme oxygenase-1spite a higher dose of glycerol (dosed on a body weight
basis), the plasma creatinine the day following the ad- (HO-1) in the glycerol model of heme protein-induced
injury [9]. Thus, we first examined the expression of HO-1ministration of hypertonic glycerol in the rats subjected
to common bile duct ligation was markedly and signifi- in the liver and kidney following ligation of the common
bile duct and the functional effect of such induction.cantly lower as compared with rats subjected to sham
operation (1.71  0.18 vs. 0.73  0.04 mg/dL, P  0.05); As demonstrated in Figure 4, there was a twofold in-
crease in expression of heme oxygenase-1 mRNA in thethe increment in plasma creatinine in rats subjected
to common bile duct ligation was markedly lower than kidney that was accompanied by increased heme oxygen-
ase activity. The induction of heme oxygenase-1 mRNAthat evinced in rats subjected to sham operation (1.41 
0.17 vs. 0.22  0.03 mg/dL, P  0.05). Thus, even when was particularly striking in the liver, wherein a 13-fold
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Fig. 3. Plasma creatine phosphokinase activity (CK, A), plasma hemoglobin concentrations (B), and plasma lactate dehydrogenase activity (LDH,
C ) six hours after the intramuscular administration of hypertonic glycerol (7.5 mL/kg body weight) in rats subjected to sham operation () or
ligation of the common bile duct (). *P  0.05 vs. mean values for this index in rats subjected to sham operation.
Fig. 4. (A) Heme oxygenase-1 mRNA ex-
pression in the kidney in rats subjected to
sham operation (SO) or ligation of the com-
mon bile duct (BDL). Each lane represents
RNA extracted from a single kidney of an
individual rat. Provided below the Northern
analysis are the standardized, individual, den-
sitometric readings and the mean standard-
ized, densitometric readings. (B) Measure-
ments of kidney heme oxygenase activity in
rats subjected to SO or BDL. *P  0.05 vs.
heme oxygenase activity in rats subjected to
sham operation (SO).
up-regulation of heme oxygenase-1 mRNA occurred fol- ity on the capacity of the common bile duct ligation to
protect against glycerol-induced acute tubular necrosis.lowing ligation of the common bile duct (Fig. 5).
To determine the role of heme oxygenase-1 expressed In studies summarized in Figure 6, all rats underwent
glycerol-induced acute renal injury; groups of rats werein the kidney and liver in the observed protection, we
examined the effect of inhibiting heme oxygenase activ- either subjected to sham operation or common bile duct
Leung et al: Acute cholestasis protects against ATN 1053
Fig. 5. Heme oxygenase-1 mRNA expression
in the liver in rats subjected to sham operation
(SO) or ligation of the common bile duct (BDL).
Each lane represents RNA extracted from a
single liver of an individual rat. Provided be-
low the Northern analysis are the standard-
ized, individual, densitometric readings, and
the mean standardized, densitometric read-
ings for each group.
these studies, in rats subjected to common bile duct liga-
tion we also measured the plasma creatinine 15 hours
after the administration of tin protoporphyrin or vehicle
but just prior to the administration of glycerol. These
studies thus allowed the examination of the acute effect
of tin protoporphyrin on plasma creatinine in rats sub-
jected to common bile duct ligation, and therefore the
assessment of the functional contribution of induced heme
oxygenase-1 in the common bile duct ligation model, albeit
acutely, and at this time point in this model. Plasma
creatinine was not significantly different in rats with liga-
tion of the common bile duct subjected to vehicle or tin
protoporphyrin (0.54  0.02 vs. 0.52  0.02 mg/dL, P 
NS). Thus, the effects observed in the studies described
previously in this article, and summarized in Figure 6,
cannot be ascribed to the effect of tin protoporphyrin
in the common bile duct ligation model per se.
Fig. 6. Plasma creatinine concentrations in rats subjected to sham oper- We also confirmed that bilirubin in concentrations thatation (SO) or ligation of the common bile duct (BDL) 24 hours after
encompass the amount present in plasma of rats sub-the administration of hypertonic glycerol (G, 7.5 mL/kg body weight)
and pretreated with either tin protoporphyrin (TP) or vehicle (V), the jected to ligation of the common bile duct does not affect
latter administered 15 hours and 3 hours prior to hypertonic glycerol.
the assay used for the determination of plasma creati-*P  0.05 for these comparisons by analysis of variance.
nine. Plasma concentrations of bilirubin are markedly
elevated in bile duct-ligated rats, as demonstrated by
such measurements in sham-operated rats and bile duct-
ligation and were treated either with an inhibitor of heme ligated rats seven days after obstruction of the biliary
oxygenase, tin protoporphyrin, or vehicle. In rats that un- tract (3.5  1.0 vs. 148.1  5.9 mol/L, P  0.05, N 
derwent sham operation, increased plasma creatinine 4 in each group). To determine whether large amounts
concentrations were observed in rats subjected to glyc- of bilirubin present in plasma would affect the assay
erol and also pretreated with tin protoporphyrin, an ef-
used for the determination of plasma creatinine, plasma
fect expected from previous studies demonstrating the
creatinine was measured in rats subjected the day pre-exacerbatory effect of tin protoporphyrin in the glycerol
viously to hypertonic glycerol (7.5 mL/kg body weight,model [9]. Following the induction of glycerol-induced
50% solution, intramuscular injection); these measure-acute renal failure, plasma creatinine was again lower in
ments were undertaken in the absence and in the pres-rats subjected to ligation of the common bile duct as
ence of bilirubin, the latter added to the plasma tocompared with rats subjected to sham operation. This
achieve a final concentration of 500 mol/L. Mean con-protective effect was significantly reduced, but not pre-
centrations of plasma creatinine  SEM were 1.93 vented, when these rats were concomitantly treated with
0.50 and 1.89  0.52 mg/dL (N  6) in the absence andtin protoporphyrin (Fig. 6). Thus, the protection con-
presence of bilirubin with a correlation coefficient offerred by common bile duct ligation arises from mecha-
0.99 between these values. Thus, the presence of bilirubinnisms that are directly dependent on intact heme oxy-
does not influence the measurement of plasma creati-genase activity and a component that appears indepen-
dent, at least acutely, of heme oxygenase activity. In nine.
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Studies employing the glycerol model at a dose
of 10 mL/kg body weight
To determine whether the protection against glycerol-
induced acute renal injury conferred by prior ligation of
the common bile duct also would be evinced in more se-
vere forms of acute renal failure, we examined the effect
of a larger dose of intramuscular glycerol (10 mL/kg body
weight) in rats subjected to common bile duct ligation or
sham operation and dosed on the basis of the mean body
weight of rats subjected to sham operation (Fig. 7). Using
this more severe form of acute renal failure, ligation of
the common bile duct was again remarkably protective
in that plasma creatinine rose sharply and markedly in Fig. 7. Effect of ligation of the common bile duct or sham operation
on renal function as measured by the concentration of plasma creatininerats subjected to sham operation, whereas the rise in
prior to and one day following the intramuscular administration ofplasma creatinine in rats subjected to common bile duct hypertonic glycerol (10 mL/kg body weight). Day 0 represents plasma
ligation prior to the administration of glycerol was again creatinine concentrations just prior to the administration of glycerol
(10 mL/kg body weight) to rats that, six days previously, were subjectednoticeably blunted. Ligation of the common bile duct
to ligation of the common bile duct () or sham operation (). Dayprotected not only against renal dysfunction, but also 1 refers to measurements of plasma creatinine concentration under-
reduced the acute cumulative mortality observed with taken one day after the injection of intramuscular glycerol (10 mL/kg
body weight) in these two groups. *P  0.05 vs. plasma creatinineglycerol-induced acute renal failure of this severity. Sur-
concentration in rats subjected to sham operation.vival in these two groups was assessed for up to five days
after the administration of glycerol. While survival was
not significantly different in rats subjected to sham oper-
ation as compared with those subjected to ligation of nine concentration and markedly less histologic evidence
the common bile duct on day 1 (93 vs. 82%, P  NS) of acute tubular necrosis in rats subjected to this surgi-
and day 2 (57 vs. 82%, PNS), survival in rats subjected cal manipulation prior to the administration of glycerol.
to ligation of the common bile duct as compared with While the precise intrarenal mechanisms accounting for
sham operation was significantly improved by day 3 (21 renal impairment in the glycerol model remains to be
vs. 82%, P  0.05), day 4 (21 vs. 73%, P  0.05), and resolved, the exposure of the kidney in the dehydrated
day 5 (21 vs. 73%, P  0.05) after the administration of state to myoglobin released from muscle and hemoglobin
glycerol. released from eythrocytes is regarded as a critical instiga-
tor of intrarenal mechanisms of injury in this model [19].Studies of heme protein-induced renal injury in vitro
To this end, we thus assessed the severity of the myoglo-
Since plasma bilirubin levels are acutely increased in bin load (by determining plasma CK) and the severity
the bile duct ligation model (3.5  1.0 vs. 148.1  of the hemoglobin load (by determining plasma hemo-
5.9 mol/L, vide supra), we considered the possibility globin concentration), and as demonstrated, plasma lev-
that bilirubin can confer protection against heme pro- els of CK were comparable while plasma levels of hemo-
tein-induced renal injury. To this end, the model of heme globin were markedly higher (Fig. 3). The basis for this
protein-mediated injury previously explored and charac-
heightened injury to red blood cells in rats subjected to
terized in our laboratory was used [30]. This in vitro
bile duct ligation prior to the administration of glycerolmodel is induced by the exposure of renal proximal tubu-
is uncertain, but may reflect the detergent effects of bilelar epithelial cells to hemoglobin in the setting of gluta-
acids that are present in markedly increased concentra-thione depletion. In this model of cell injury, cytotoxicity
tions in the circulation following obstruction of the bili-was assessed by LDH release, and the effect of increasing
ary tract. These data thus demonstrate that the observedconcentrations of bilirubin was examined (Fig. 8). As
protective effects proffered by prior ligation of the com-demonstrated, bilirubin exhibited a significant dose-
mon bile duct may not be ascribed to reduction in myo-dependent cytoprotection in the low micromolar range,
lysis or hemolysis or to diminished exposure of the kid-effecting a 63% reduction in LDH release at a concentra-
ney to these endogenous toxicants. It also is unlikelytion of 10 mol/L bilirubin.
that the reduction in glomerular filtration rate and renal
blood flow that occur in the bile duct-ligated model serves
DISCUSSION as a protectant, since such impairment in renal function
exacerbates the effects of nephrotoxins and thus is anOur studies demonstrate that ligation of the common
alteration that increases the risk for nephrotoxic injurybile duct in the rat protects against glycerol-induced acute
tubular necrosis, as reflected by a lower plasma creati- [3, 4]. The protective effect of prior ligation of the com-
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Fig. 8. Effect of increasing concentrations of
bilirubin on cytotoxicity in LLC-PK1 cells in-
duced by exposure to chlorodinitrobenzene
(CDNB) and hemoglobin and assessed by the
LDH release assay. *P  0.05 vs. % LDH
release in the absence of bilirubin.
mon bile duct was again observed when more severe function and mortality observed in this model [9]. Addi-
tionally, studies in heme oxygenase-1 knockout miceacute renal injury was induced by larger doses of glycerol
and, in this circumstance, was associated with a reduction demonstrate that the genetic deletion of heme oxygen-
ase-1 renders mice exquisitely sensitive to heme protein-in the acute mortality so incurred.
The present studies were designed to examine the ef- induced renal injury, when the latter is induced by the
glycerol model or by a specific heme protein such asfect of prior induction of acute cholestatic liver disease
on the course of glycerol-induced acute tubular necro- hemoglobin [20].
Expression of heme oxygenase-1 was thus assessed insis; these studies were not designed to examine the effect
of glycerol-induced acute renal failure on the course of the kidney and liver. Such expression of heme oxygenase-1
was increased in the kidney and markedly so in the liver.acute cholestatic liver disease. Since the course of glyc-
erol-induced acute renal failure is determined by func- While the basis for this marked up-regulation in heme
oxygenase-1 remains uncertain at the present time, po-tional and structural alterations occurring within days
of this insult [9], we thus evaluated the effect of such tential mechanisms include such possibilities as oxidative
stress [31, 32] and elevated systemic levels of cytokinesliver disease on glycerol-induced renal injury on days 1
through 5 after the induction of acute renal injury. Be- [8], which occur in this model and which are recognized
inducers of heme oxygenase-1. Such induction of hemeyond the latter time point, there is mounting mortality
from ligation of the common bile duct per se [2]. Since oxygenase-1 conferred a functional effect since the prior
administration of a competitive inhibitor of heme oxygen-our studies were not designed to assess the interacting
effect of these two insults beyond the period when the ase attenuated the protection that was conferred by com-
mon bile duct ligation. Thus, induction of heme oxygen-course of glycerol-induced acute renal failure is critically
determined (such as, and approximately, days 1 through ase-1 that occurs following ligation of the common bile
duct contributes to the observed acquisition of resistance5) [9, 19] or to assess the effect of glycerol induced-acute
renal failure on acute cholestasis in the rat, observations to glycerol-induced, heme protein-mediated renal injury.
A significant component of resistance so acquired,were not continued beyond this time point.
To determine the mechanisms that may underlie this however, remains uninfluenced by inhibition of heme
oxygenase activity, thereby raising the possibility thatprotective effect, we considered the possibility that heme
oxygenase-1 is involved. Prior studies demonstrate that other mechanisms may be involved. We suggest that the
protective effects of ligation of the common bile ductthe induction of heme oxygenase-1 confers a cytoprotec-
tive response in heme protein-mediated renal injury. In also may arise, in part, from the hyperbilirubinemia that
occurs in this model (more than a 40-fold increase asthe glycerol model, marked and early induction of heme
oxygenase-1 occurs: Inhibition of heme oxygenase activ- compared with plasma concentration of bilirubin in sham
operated rats), a suggestion supported by studies under-ity worsens renal function in this model, while the prior
induction of heme oxygenase-1 protects against renal dys- taken in a cell culture model of heme protein-induced
Leung et al: Acute cholestasis protects against ATN1056
renal injury. In this latter model, bilirubin, in the low duction of heme oxygenase-1—that are notably dis-
played in this model of liver disease.micromolar range, confers significant dose-dependent
cytoprotection against lytic cell death, thereby demon- We suggest that our observations are relevant to the
pathogenesis of acute renal failure observed in the set-strating the potent ability of bilirubin to protect renal
epithelial cells against heme protein-induced renal in- ting of acute hepatic failure from two perspectives. The
first pertains to the occurrence of the hepatorenal syn-jury. An additional possibility may involve ferritin since
this iron-binding protein is incriminated as a protectant drome [1, 42]. Remarkably, the dysfunctional kidney in
the hepatorenal syndrome can, in fact, function normallyin the glycerol model [9], and plasma concentrations of
ferritin are significantly increased following obstruction when freed from the setting of liver failure, as indicated
by the resumption of normal renal function when theseto the biliary tract [33].
To our knowledge, these effects of bilirubin represent kidneys are transplanted into patients with normal liver
function [1, 42]. That renal dysfunction in the hepatore-the first demonstration of a cytoprotective action of bili-
rubin against acute cell injury induced in cells derived nal syndrome is entirely reversible and that significant
renal structural injury does not occur in this syndromefrom the kidney; these data also add to the accumulating
body of evidence attesting to such effects of bilirubin in suggest that in the inimical setting of liver failure—the
latter exposing the kidney to numerous potentially toxicacutely injured tissue. For example, bilirubin in micro-
molar quantities scavenges peroxyl radicals generated in species and rendering the kidney prone to ischemic and
certain nephrotoxic insults—the kidney is somehow pro-homogenous solutions or in liposomes [24], actions that
may be exhibited by bilirubin in plasma in vivo [25–27]; tected against irreversible structural and functional dam-
age. This suggests the concomitant presence of some cyto-bilirubin in nanomolar or micromolar quantities can re-
duce oxidant-induced injury in vitro to neurons [34], protective mechanism that safeguards the kidney and
one that may offer insights germane to the issue of organsmooth muscle cells [35], myocytes [36], and human tra-
cheal epithelial cells [37]. In the isolated rat heart prepa- preservation. Based on our findings, we suggest that the
induction of heme oxygenase-1 and/or bilirubin may beration, bilirubin in nanomolar quantities protects against
myocardial dysfunction and reduces the extent of in- potential candidates for conferring such cytoprotection
and assisting in organ preservation in this setting.farction and mitochondrial dysfunction induced by isch-
emia [38]. Bilirubin may exert an antioxidant capability We also suggest that our findings have implications for
the clinical perspective that patients with advanced liverin vivo. For example, the prior administration of bilirubin
blocks the decrease in glutathione (GSH) and the in- disease or hepatic failure are unduly susceptible to acute
tubular necrosis [1–4]. Our findings indicate that abnor-crease in oxidant-dependent chemiluminescence that oc-
cur in the liver following the administration of heavy malities arising as a consequence of cholestatic liver dis-
ease are not uniformly injurious but, indeed, includemetals [39, 40]. Such administration of bilirubin also
blocks the increase in lipid peroxidation and the reduc- alterations that may be cytoprotective for certain insults,
specifically those insults that are ameliorated by salutarytion in GSH that occur in the liver in response to ultravio-
let A (UVA) radiation [41]. actions of heme oxygenase-1 and its product, bilirubin.
For such insults, the induction of heme oxygenase-1 andIt is noteworthy that prior ligation of the common bile
duct in the rat confers resistance to glycerol-induced the presence of copious amounts of bilirubin may offset
other features of liver disease—biochemical as well asacute renal failure, especially since previous studies con-
clude that this form of liver injury sensitizes the kidney hemodynamic—that predispose to renal injury.
In summary, our studies demonstrate a novel form ofto injury from ischemia, endotoxin, and gentamicin [5–8].
The glycerol model—much more so than these other acquired resistance to renal injury, wherein ligation of
the common bile duct confers resistance to glycerol-models—is one in which induction of heme oxygenase-1
confers a potent protective response [21–23]. The robust induced acute renal failure. That acquired resistance oc-
curs in the setting of acute cholestatic liver disease isinduction of heme oxygenase-1, as occurs in the glycerol
model, generates copious quantities of bilirubin, and unexpected, especially since the prevailing view is that
the kidney in this milieu is predictably and persistentlythese two features—the induction of heme oxygenase-1
and the ready availability of one of its cytoprotectant prone to acute tubular necrosis. Our findings raise the
possibility that certain alterations occurring in the settingproducts, namely, bilirubin—are both prominently ex-
hibited following ligation of the common bile duct. That of the failing or failed liver—in particular, the induction
of heme oxygenase-1 and the acute elevations in systemicthe glycerol model stands in apparent contrast to these
other models of acute tubular necrosis with regards to concentrations of bilirubin—may confer resistance to re-
nal injury. Finally, we speculate that such potentially cyto-protection conferred by ligation of the common bile duct
may reflect the presence of these two features—acute protective alterations may enable the kidney in the he-
patorenal syndrome to endure this otherwise inimicalelevation in systemic concentrations of bilirubin and in-
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